Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Comparing a vibrating pelvic floor device to traditional vaginal dilators for treating entry dyspareunia

Official title: VIBRENT- VIBRating vs Traditional Therapy for Treatment of ENTry Dyspareunia

Run by Medstar Health Research Institute · NCT06840314 · Data updated 2026-11-12

This study is testing whether a new vibrating pelvic floor device can help women with pain during sex feel better compared to using traditional vaginal dilators.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment60 (estimated)
SponsorMedstar Health Research Institute
Academic / other
Drugs / interventionsradiation
Locations1 site (Washington D.C., District of Columbia)
StatusRecruiting
StartedMarch 1, 2025
Main results expectedNovember 2025
Study endsMarch 2026
Registry record updatedMay 21, 2025
Trial IDNCT06840314 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 18 and older who have been diagnosed with genito-pelvic pain/penetration disorder.

Probably not a fit

Patients with unmanaged genitourinary syndrome of menopause or a history of pelvic radiation or genital tract malignancy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial evaluates the effectiveness of a novel vibrating pelvic floor therapeutic device, known as the 'Kiwi', in improving sexual function in sexually active women aged 18 and older with genito-pelvic pain and penetration disorder (GPPPD). Participants will be randomly assigned to use either the Kiwi device or traditional vaginal dilators three times a week for 15 minutes over four weeks. The study aims to determine if the Kiwi device leads to higher sexual function scores and greater improvements in sexual distress, pain, and overall symptom severity compared to traditional methods. Data will be collected using validated questionnaires at baseline and after the intervention period.

Why it matters

Potential benefit: If successful, this study could provide a more effective treatment option for women suffering from genito-pelvic pain and penetration disorders.

How similar studies have gone: While the use of vibrating devices for pelvic therapy is emerging, this specific approach comparing the Kiwi device to traditional dilators is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Assigned female at birth
* Age ≥ 18 years old
* Genito-pelvic pain/penetration disorder (per ICD-10 diagnosis codes: F52.5 Vaginismus not due to a substance or known physiological condition, F52.6 Dyspareunia not due to a substance or known physiological condition, N94.1 Dyspareunia, N94.2 Vaginismus, N94.81 Vulvodynia)

Exclusion Criteria:

* Current or prior use of a therapeutic vaginal device used to treat GPPPD
* Unmanaged genitourinary syndrome of menopause
* History of pelvic radiation
* History of genital tract malignancy
* History of female genital mutilation
* History of prior surgery for prolapse or incontinence, including vaginal mesh or midurethral sling mesh
* Silicone allergy

Where it's running

  • MedStar Health
    Washington D.C., District of Columbia, United States
    Recruiting

Study contacts

  • Principal investigator: Cheryl Iglesia, MD — Medstar Washington Hospital Center National Center for Advanced Pelvic Surgery
  • Study coordinator: Helen Y Zhang, MD
  • Email: helen.y.zhang@medstar.net
  • Phone: 202-877-6526

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.